title: New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Reiner
mesh_terms: D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000628:therapy*; D005060:Europe; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D017410:Practice Guidelines as Topic; D011314:Preventive Health Services / Q000592:standards*; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012955:Societies, Medical / Q000592:standards*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D000960:Hypolipidemic Agents; D008055:Lipids